Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Janine P. White"'
Publikováno v:
BMJ Open, Vol 14, Iss 12 (2024)
Introduction The knowledge gaps on the experiences of early career health professionals during the COVID-19 pandemic informed this study, which examined their vaccination status, personal and workplace experiences in South Africa.Methods Wits longitu
Externí odkaz:
https://doaj.org/article/8b1688bfddbc441f9cd88cb742f97714
Autor:
Janine A. White, Laetitia C. Rispel
Publikováno v:
Global Health Action, Vol 17, Iss 1 (2024)
Background Notwithstanding the global goal of inclusive universal health coverage, and the notion of migrant-sensitive health systems, limited healthcare access or the exclusion of migrants from national health systems persists. South Africa has a ri
Externí odkaz:
https://doaj.org/article/245b85e030e449ee9c80f4b1272e312f
Autor:
Alexander L Lundberg, Ramon Lorenzo-Redondo, Judd F Hultquist, Claudia A Hawkins, Egon A Ozer, Sarah B Welch, P V Vara Prasad, Chad J Achenbach, Janine I White, James F Oehmke, Robert L Murphy, Robert J Havey, Lori A Post
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 6, p e37377 (2022)
BackgroundThe Omicron variant of SARS-CoV-2 is more transmissible than prior variants of concern (VOCs). It has caused the largest outbreaks in the pandemic, with increases in mortality and hospitalizations. Early data on the spread of Omicron were c
Externí odkaz:
https://doaj.org/article/04eef9bb6060457986fa46d6fa0f934c
Autor:
Alexander L Lundberg, Ramon Lorenzo-Redondo, Egon A Ozer, Claudia A Hawkins, Judd F Hultquist, Sarah B Welch, PV Vara Prasad, James F Oehmke, Chad J Achenbach, Robert L Murphy, Janine I White, Robert J Havey, Lori Ann Post
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 1, p e35763 (2022)
BackgroundVariants of the SARS-CoV-2 virus carry differential risks to public health. The Omicron (B.1.1.529) variant, first identified in Botswana on November 11, 2021, has spread globally faster than any previous variant of concern. Understanding t
Externí odkaz:
https://doaj.org/article/8da8c2472be341cb9aaa0b5be4f92a6a
Publikováno v:
Global Health Action, Vol 13, Iss 1 (2020)
Background: There is global emphasis on quality universal health coverage (UHC) that is responsive to the needs of vulnerable communities, such as migrants. Objective: Examine the perceptions of migrants on health system responsiveness (HSR) and thei
Externí odkaz:
https://doaj.org/article/484a2f033385418db4927c663a17746c
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244080 (2020)
BackgroundUniversal health coverage (UHC) for all people, regardless of citizenship, is a global priority. Health care providers are central to the achievement of UHC, and their attitudes and behaviour could either advance or impede UHC for migrants.
Externí odkaz:
https://doaj.org/article/c54cdb320d2a4f74a58948a54f6d61ac
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223739 (2019)
BACKGROUND:The human resources for health (HRH) crisis and dearth of research on the health labour market in South Africa informed the WiSDOM (Wits longitudinal Study to Determine the Operation of the labour Market among its health professional gradu
Externí odkaz:
https://doaj.org/article/adff817a53d04f9ca277cf0c7d52d739
Publikováno v:
Tubercle. 66:145-149
A case of extensive bone and joint tuberculosis is reported in a 62-year-old caucasian woman who had a 25 year history of inadequately treated facial lupus vulgaris. In spite of a good response to standard anti-tuberculosis chemotherapy there was ext
Autor:
Janine P. White, Noemi M. Eiser
Publikováno v:
British Journal of Diseases of the Chest. 77:215-226
Histamine was implicated first in the pathogenesis of asthma in 1919 when Dale and Laidlaw produced an anaphylactic reaction associated with respiratory distress by infusing intravenous histamine in laboratory animals. When Weiss et al. (1928) gave i
Publikováno v:
British Journal of Diseases of the Chest. 76:57-60
Twenty patients with chronic bronchitis who were also receiving β-agonist inhalers entered a single-blind cross-over study comparing slow-release aminophylline (Phyllocontin) 325 mg twice daily and slow-release theophylline (Rona-slophyllin) 250 mg